Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Mar;114(3):224-236.
doi: 10.1007/s00347-016-0370-1.

[Current diagnostics and therapy recommendations for ocular basal cell carcinoma]

[Article in German]
V Kakkassery  1 , K U Loeffler  2 , M Sand  3   4 , K R Koch  5 , A M Lentzsch  5 , A C Nick  6 , I A Adamietz  7 , L M Heindl  5
Affiliations
Review

[Current diagnostics and therapy recommendations for ocular basal cell carcinoma]

[Article in German]
V Kakkassery et al. Ophthalmologe. 2017 Mar.

Abstract

The treatment options for basal cell carcinoma (BCC) have recently been augmented with the introduction of novel chemotherapeutic drugs. New S2 guidelines on the disease have also been published. The aim of this article is to present a comprehensive state of the art description of the features of ocular BCC and an overview of the various therapeutic options. Particular emphasis is placed on the clinical signs, the diagnostic tools to identify periocular BCC and interpretation of the different histopathological subtypes. Tumor staging, TNM classification, interdisciplinary tumor conference reviews as well as psycho-oncological services play an important role in patients with pronounced periocular BCC. Surgical removal with a histological R0 resection is an important component of therapy options in this disease and includes the microsurgical excision into healthy tissue and the subsequent covering of the defect. A special focus of this article is the treatment of locally extensive and metastasized BCC.

Keywords: Chemotherapeutic drugs; Histology; Microsurgery; Pathology; Tumors.

PubMed Disclaimer

References

    1. Ophthalmologe. 2011 Jan;108(1):33-7 - PubMed
    1. Int J Radiat Oncol Biol Phys. 1995 Jul 30;32(5):1347-50 - PubMed
    1. Br J Dermatol. 2014 Nov;171(5):968-73 - PubMed
    1. Clin Cancer Res. 2011 Apr 15;17 (8):2502-11 - PubMed
    1. Am J Pathol. 2001 Feb;158(2):381-5 - PubMed

MeSH terms

LinkOut - more resources